RECRUITING

High-Resolution Lower Dose Dedicated Breast Computed Tomography (CT)

Talk to us

Conditions

Breast Cancer

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study is being performed to find out if a new kind of breast imaging (called dedicated breast CT or BCT) can help doctors to see the small structures in breast tissue more clearly. The investigators also want to find out if using the BCT will provide a more accurate diagnosis of breast cancer.

Official Title

Study of High-resolution, Lower Dose Dedicated Breast CT.

Quick Facts

Study Start:2025-08-14
Study Completion:2029-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03954431

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:40 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * who are 40 years of age or older (typical screening age range)
  2. * who are undergoing or scheduled for screening or diagnostic imaging, or need a biopsy to investigate an abnormality in the breast.
  1. * Males,
  2. * women less than 40 years old,
  3. * women unable to self-consent,
  4. * prisoners,
  5. * pregnant, suspected to be pregnant, or lactating women (self-reported)
  6. * women with physical limitations that may prohibit resting prone on the exam table, such as, but not limited to: frozen shoulder, recent heart surgery, pace maker;
  7. * women who are unable to tolerate study constraints, frail, or unable to cooperate;
  8. * women who weigh more than 440 lbs (200 Kg), which is the weight limit for the patient support table of the BCT system;
  9. * women who have received radiation treatments to the thorax for malignant and nonmalignant conditions, such as (but not limited to) treatment for enlarged thymus gland as an infant, irradiation for benign breast conditions, including breast inflammation after giving birth, and treatment for Hodgkin's disease;
  10. * women who have participated in a prior breast clinical trial that gave additional radiation dose, such as an additional mammogram;
  11. * women who have received large number of diagnostic x-ray examinations for monitoring of disease such as (but not limited to) tuberculosis, and severe scoliosis.

Contacts and Locations

Study Contact

Michele Galvan, R.T.R.
CONTACT
520-626-2279
mngalvan@arizona.edu

Principal Investigator

Srinivasan Vedantham, PhD
PRINCIPAL_INVESTIGATOR
University of Arizona

Study Locations (Sites)

University of Arizona
Tucson, Arizona, 85724
United States

Collaborators and Investigators

Sponsor: University of Arizona

  • Srinivasan Vedantham, PhD, PRINCIPAL_INVESTIGATOR, University of Arizona

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-08-14
Study Completion Date2029-12

Study Record Updates

Study Start Date2025-08-14
Study Completion Date2029-12

Terms related to this study

Additional Relevant MeSH Terms

  • Breast Cancer